长春西汀联合曲克芦丁脑蛋白水解物治疗急性脑梗死的临床效果以及药理分析  

Clinical Effect and Pharmacological Analysis of Vinpocetine Combined with Troxerutin Brain Protein Hydrolysate in the Treatment of Acute Cerebral Infarction

作　　者：董卫 DONG Wei(Department of Pharmacy,Xinhua Hospital Affiliated to Dalian University,Dalian 116000,China)

机构地区：[1]大连大学附属新华医院药剂科,辽宁大连116000

出　　处：《中国医药指南》2021年第30期70-71,共2页Guide of China Medicine

摘　　要：目的探讨长春西汀联合曲克芦丁脑蛋白水解物治疗急性脑梗死的临床效果以及药理分析。方法选取在大连大学附属新华医院就诊的80例急性脑梗死患者为研究对象,时间为2018年1月至2019年1月,随机分为试验组和对照组。两组均给予常规治疗。在常规治疗的基础上,对照组40例采取长春西汀治疗,试验组采取长春西汀联合曲克芦丁脑蛋白水解物治疗。通过神经功能缺损情况比较两组患者的临床有效率。结果试验组临床有效率为97.50%,对照组临床有效率为90.00%,试验组优于对照组,差异有统计学意义(P<0.05)。结论对急性脑梗死患者采取长春西汀联合曲克芦丁脑蛋白水解物治疗,效果显著,值得在临床推广。Objective To investigate the clinical effect and pharmacological analysis of vinpocetine combined with troxerutin brain protein hydrolysate on the treatment of acute cerebral infarction.Methods Eighty patients with acute cerebral infarction admitted to Xinhua Hospital Affiliated to Dalian University from January 2018 to January 2019 were randomly divided into experimental group and control group.Both groups were given routine treatment.On the basis of conventional treatment,40 patients in the control group were treated with vinpocetine,and the experimental group was treated with vinpocetine combined with troxerutin brain protein hydrolysate.The clinical efficiency of two groups of patients was compared by the neurological defect.Results The clinical effective rate of the experimental group was 97.50%,and that of the control group was 90.00%.The experimental group was superior to the control group,and the difference was statistically significant(P<0.05).Conclusion Vinpocetine combined with troxerutin brain protein hydrolysate in the treatment of patients with acute cerebral infarction is effective and worthy of clinical promotion.

关 键 词：长春西汀 曲克芦丁脑蛋白水解物 急性脑梗死 临床效果 药理分析 

分 类 号：R743.33[医药卫生—神经病学与精神病学]